Ticker,Title,Link
LXEO,Buy Rating for Lexeo Therapeutics Backed by Strong Finances and Promising Clinical Trials,8/14/2024 1:35:18 AM
LXEO,Buy Rating on Lexeo Therapeutics: Promising Clinical Advancements and Strategic FDA Engagement,8/13/2024 2:09:26 PM
LXEO,LXEO Stock Earnings: Lexeo Therapeutics Beats EPS for Q2 2024,8/12/2024 5:54:35 PM
LXEO,"Stifel Nicolaus Reaffirms Their Buy Rating on Lexeo Therapeutics, Inc. (LXEO)",7/29/2024 11:46:23 AM
LXEO,Promising Interim Clinical Trial Results Bolster Confidence in Lexeo Therapeutics’ Gene Therapy Potential,7/18/2024 7:07:26 AM
LXEO,Lexeo Down Despite Upbeat Rare Disease Gene Therapy Data,7/17/2024 5:48:19 PM
LXEO,"Analysts Are Bullish on These Healthcare Stocks: Instil Bio (TIL), Lexeo Therapeutics, Inc. (LXEO)",7/16/2024 10:20:46 AM
LXEO,Buy Rating Affirmed for Lexeo Therapeutics Amid Promising Clinical Trial Results for FA-CM Treatment,7/15/2024 7:05:21 PM
LXEO,"Lexeo Therapeutics Announces Investor Webcast to Report Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy on Monday, July 15, 2024",7/11/2024 2:00:00 PM
LXEO,Lexeo Therapeutics Appoints Tim Van Hauwermeiren to its Board of Directors,7/8/2024 1:00:00 PM
LXEO,"Analysts Conflicted on These Healthcare Names: Equillium (EQ), Lexeo Therapeutics, Inc. (LXEO) and Teladoc (TDOC)",6/6/2024 10:20:37 AM
LXEO,"Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), Krystal Biotech (KRYS) and Veeva Systems (VEEV)",5/31/2024 12:10:53 PM
LXEO,"Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), RAPT Therapeutics (RAPT) and Hookipa Pharma (HOOK)",5/14/2024 8:40:31 AM
LXEO,"RBC Capital Remains a Buy on Lexeo Therapeutics, Inc. (LXEO)",5/10/2024 10:41:31 AM
LXEO,Lexeo Therapeutics reports Q1 results,5/9/2024 1:49:29 PM
LXEO,Lexeo Therapeutics to Participate in Upcoming Investor Conferences,5/7/2024 1:30:00 PM
LXEO,"IPO Roundup: Viking Holdings, RanMarine Technology, and more",4/29/2024 1:33:33 PM
LXEO,Buy Rating Affirmed for Lexeo Therapeutics Amid Strategic Cornell Collaboration and Promising Therapy Advancements,4/26/2024 6:07:59 AM
LXEO,Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy,4/22/2024 1:30:00 PM
LXEO,Lexeo's LX2006 Gene Therapy Gets FDA Fast Track Designation; Stock Up In Pre-market ,4/16/2024 2:32:01 PM
LXEO,Lexeo Therapeutics files to sell 6.97M shares of common stock for holders,4/9/2024 1:02:45 PM
LXEO,"Stifel Nicolaus Reaffirms Their Buy Rating on Lexeo Therapeutics, Inc. (LXEO)",3/14/2024 2:05:16 AM
LXEO,Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing,3/13/2024 9:22:39 PM
LXEO,RBC Capital Maintains Outperform Rating for Lexeo Therapeutics: Here's What You Need To Know,3/12/2024 6:00:16 PM
LXEO,Lexeo Therapeutics announces $95M private equity placement,3/11/2024 4:08:57 PM
LXEO,"Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday",3/6/2024 5:45:29 PM
LXEO,"3 Best Stocks to Buy Now, 2/12/2024, According to Top Analysts ",2/12/2024 9:39:55 AM
LXEO,"Lexeo Therapeutics, Inc. (LXEO) Receives a Buy from Stifel Nicolaus",2/9/2024 1:29:34 PM
LXEO,Lexeo Therapeutics Bolsters Leadership with Key Hires,2/6/2024 9:10:44 AM
LXEO,Lexeo Therapeutics announces new executive appointments,2/5/2024 2:37:06 PM
LXEO,"Analysts Conflicted on These Healthcare Names: Lexeo Therapeutics, Inc. (LXEO) and Andlauer Healthcare Group (OtherANDHF)",1/19/2024 1:50:40 AM
LXEO,Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session,1/18/2024 7:08:49 PM
LXEO,"Lexeo Therapeutics, Inc. (LXEO) Receives a Buy from RBC Capital",1/6/2024 1:47:00 AM
LXEO,Lexeo Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference,1/3/2024 1:00:00 PM
LXEO,"Marathon Digital, Canaan, CleanSpark And Other Big Stocks Moving Lower On Tuesday",12/26/2023 4:16:03 PM
LXEO,Lexeo Therapeutics Says FDA Grants Fast Track And Orphan Drug Designation To LX2020 ,12/18/2023 1:25:36 PM
LXEO,Stable Execution and Positive Clinical Progress Support $19 Price Target for Lexeo Therapeutics,12/13/2023 6:16:51 AM
LXEO,LXEO Stock Earnings: Lexeo Therapeutics Reported Results for Q3 2023,12/11/2023 5:05:23 PM
LXEO,J.P. Morgan Recommends These 2 ‘Strong Buy’ Stocks With Over 60% Upside Potential,11/30/2023 1:42:00 PM
LXEO,Buy Rating Affirmed for Lexeo Therapeutics on Promising Gene Therapy Innovations and Strong Management,11/28/2023 9:36:43 AM
